Patients with cirrhosis develop complex alterations in primary hemostasis that include both
hypocoagulable and hypercoagulable features. This includes thrombocytopenia, multiple …

The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …

Background & Aims Bacterial infections in cirrhosis are associated with increased bleeding
risk. To assess the factors responsible for bleeding tendency in patients with bacterial …

Methods We conducted a literature search of relevant databases to identify studies that
reported post-ERCP complications in patients with hepatic cirrhosis. Results Twenty-four …

Abstract Background Extracellular vesicles (EVs) modulate inflammation, coagulation and
vascular homeostasis in decompensated cirrhosis. Aim To characterize the profile of …

Introduction Liver cirrhosis is accompanied by several hemostatic alterations, which
contribute to the current theory of “rebalanced hemostasis.” Splanchnic vein thrombosis …

Results A total of 16 studies with data on 13,378 patients were included in the meta-
analysis. Among 34 parameters, 14 parameters were assessed for association with early …

Acute and chronic liver disease is associated with significant hematologic disturbances.
Patients frequently develop multifactorial cytopenias and coagulopathy related to alterations …

Introduction The safety of continuing anticoagulation therapy during endoscopic variceal
ligation (EVL) remains controversial. We performed a systematic review and meta‐analysis …

This review addresses the peri-procedural bleeding risks in patients with cirrhosis,
emphasizing the need for careful coagulation assessment and targeted correction …